Invesco Ltd. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 135 filers reported holding OCULAR THERAPEUTIX INC in Q2 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$784,809
-14.8%
249,939
+40.0%
0.00%
Q2 2023$921,313
+3.4%
178,549
+5.6%
0.00%
Q1 2023$891,431
+19.4%
169,152
-36.4%
0.00%
Q4 2022$746,822
+32.4%
265,773
+95.4%
0.00%
Q3 2022$564,000
-18.8%
135,985
-21.4%
0.00%
Q2 2022$695,000
-12.5%
172,943
+7.9%
0.00%
Q1 2022$794,000
-16.9%
160,324
+16.9%
0.00%
Q4 2021$955,000
-10.2%
137,099
+28.8%
0.00%
Q3 2021$1,064,000
-15.2%
106,441
+20.2%
0.00%
Q2 2021$1,255,000
+22.6%
88,518
+41.9%
0.00%
Q1 2021$1,024,000
-95.1%
62,372
-93.8%
0.00%
-100.0%
Q4 2020$20,718,000
+1333.8%
1,000,896
+427.2%
0.01%
Q3 2020$1,445,000
-71.2%
189,841
-68.5%
0.00%
-100.0%
Q2 2020$5,020,000
+629.7%
602,673
+333.6%
0.00%
Q1 2020$688,000
-39.4%
138,979
-51.4%
0.00%
Q1 2019$1,136,000
+31.2%
286,118
+31.5%
0.00%
Q4 2018$866,000
+257.9%
217,648
+519.4%
0.00%
Q3 2018$242,000
+36.7%
35,138
+34.2%
0.00%
Q2 2018$177,000
+205.2%
26,183
+846.3%
0.00%
Q2 2015$58,0002,7670.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2023
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders